Phreesia Total Current Liabilities 2019-2025 | PHR

Phreesia total current liabilities from 2019 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Phreesia Annual Total Current Liabilities
(Millions of US $)
2025 $114
2024 $110
2023 $79
2022 $68
2021 $55
2020 $35
2019 $28
2018 $0
Phreesia Quarterly Total Current Liabilities
(Millions of US $)
2025-01-31 $114
2024-10-31 $109
2024-07-31 $102
2024-04-30 $108
2024-01-31 $110
2023-10-31 $98
2023-07-31 $85
2023-04-30 $83
2023-01-31 $79
2022-10-31 $73
2022-07-31 $72
2022-04-30 $71
2022-01-31 $68
2021-10-31 $65
2021-07-31 $58
2021-04-30 $51
2021-01-31 $55
2020-10-31 $42
2020-07-31 $38
2020-04-30 $38
2020-01-31 $35
2019-10-31 $32
2019-07-31 $39
2019-04-30
2019-01-31
2018-10-31
2018-07-31
2018-01-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.385B $0.420B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.151B 48.75
Hims & Hers Health (HIMS) United States $11.939B 124.05
Tempus AI (TEM) United States $9.210B 0.00
IRhythm Technologies (IRTC) United States $4.513B 0.00
Inspire Medical Systems (INSP) United States $4.137B 64.64
Privia Health (PRVA) United States $2.813B 192.25
Enovis (ENOV) United States $1.861B 10.37
Clover Health Investments (CLOV) United States $1.593B 0.00
Schrodinger (SDGR) United States $1.579B 0.00
Omnicell (OMCL) United States $1.376B 24.27
Azenta (AZTA) United States $1.241B 57.66
10x Genomics (TXG) United States $1.091B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Fulgent Genetics (FLGT) United States $0.626B 0.00
Talkspace (TALK) United States $0.495B 148.00
Veradigm (MDRX) United States $0.460B 0.00
Claritev (CTEV) United States $0.438B 0.00
Standard BioTools (LAB) United States $0.414B 0.00
TruBridge (TBRG) United States $0.358B 793.33
Outset Medical (OM) United States $0.346B 0.00
Nyxoah SA (NYXH) Belgium $0.267B 0.00
Health Catalyst (HCAT) United States $0.256B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.135B 0.00
EUDA Health Holdings (EUDA) Singapore $0.132B 0.00
Pulmonx (LUNG) United States $0.119B 0.00
American Well (AMWL) United States $0.109B 0.00
MDxHealth SA (MDXH) Belgium $0.100B 0.00
CareCloud (CCLD) United States $0.087B 3.31
111 (YI) China $0.068B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
Zepp Health (ZEPP) Netherlands $0.036B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00